Biologic Drugs With Established Pharmaceutical Class: Interleukin-6 Receptor Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Interleukin-6 Receptor Antagonist
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | 2010-01-08 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
